Cargando…
Multiobjective optimization identifies cancer-selective combination therapies
Combinatorial therapies are required to treat patients with advanced cancers that have become resistant to monotherapies through rewiring of redundant pathways. Due to a massive number of potential drug combinations, there is a need for systematic approaches to identify safe and effective combinatio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793282/ https://www.ncbi.nlm.nih.gov/pubmed/33370253 http://dx.doi.org/10.1371/journal.pcbi.1008538 |